Mercado fechado

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Preço Adiado. Moeda em USD.
Adicionar à lista
504,15+9,98 (+2,02%)
No fechamento: 4:02PM EDT

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
http://www.bio-rad.com

Setor(es)Healthcare
IndústriaMedical Devices
Funcionários Integrais8.000

Principais Executivos

NomeTítuloPagarExercidoNascido em
Mr. Norman D. SchwartzChairman, CEO & Pres2,12M8,17M1950
Mr. Ilan DaskalExec. VP & CFO754,23kN/A1966
Dr. Andrew J. LastExec. VP & COO825,67kN/A1960
Mr. Michael CrowleyExec. VP of Global Commercial Operations663,07kN/A1962
Ms. Annette TumoloExec. VP & Pres of Life Science Group769,91kN/A1955
Os valores são a partir de 31 de dezembro de 2019, e os valores de compensação são relativos ao ano fiscal terminando naquela data. O pagamento é salário, bônus, etc. Exercido é o valor de opções exercidas durante o ano fiscal. Moeda em USD.

Descrição

Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Governança Corporativa

O QualityScore de governança da ISS da Bio-Rad Laboratories, Inc. a partir de 9 de dezembro de 2019 é 10. As principais pontuações para Auditoria são: 3; Conselho: 10; Direitos de Acionistas: 10; Compensação: 8.

Pontuações em governança corporativa são cortesia da Institutional Shareholder Services (ISS). As pontuações indicam a posição do decil em relação ao índice ou à região. Uma decil com pontuação 1 indica menor risco de governança, enquanto uma pontuação 10 indica um maior risco de governança.